Peer Review History
| Original SubmissionNovember 9, 2024 |
|---|
|
Dear Dr. Seo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 25 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Junghwan Kim Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: “This project was supported to Dr. D.-C. Seo by the Office of Minority Health (OMH) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (CPIMP221346). For more information, please visit https://www.minorityhealth.hhs.gov/. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by OMH/OASH/HHS, or the U.S. Government.” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: ‘This work was supported by the Indiana University Center for Survey Research (CSR). We thank the CSR for assisting in administering community surveys in our target study area which greatly assisted the research although they may not agree with all of the interpretations/conclusions of this paper.” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This project was supported to Dr. D.-C. Seo by the Office of Minority Health (OMH) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (CPIMP221346). For more information, please visit https://www.minorityhealth.hhs.gov/. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by OMH/OASH/HHS, or the U.S. Government.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: Yes Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: 1- the response rate is relatively lo 23% 2- what are the steps taken to calculate demographic matching? 3- you used OOKS and OOAS without any clarifications for the psychometric validation? 4- There is a significant finding that Black participants in high-poverty areas had lower knowledge scores than their White . However, the mechanisms or contributing factors are not well explored 5- in limitation section you should mention social bias and lack of qualitative data and sing only 10 knowledge and 7 competency items 6- the method section should include response rate the different approach 7- table 2 is dense 8- add some diagrams or graphs 9- language and grammar editing Reviewer #2: This article may be corrected as follows : In abstract should be explained briefly related to IMRAD, furthermore in abstract also explained what becomes Novelty. In the introduction, I have not found any Research Gap, so researchers need to improve; wherefrom the Research Gap, researchers can give something new from this research, and I have not found what is offered by researchers as Novelty. Literature review explains how previous studies work, and you can tell what you find in previous research and what you find new from this research. In the methodology may need to be explained in more detail related to the research subject so that it becomes clear who is the subject. In results and discussion should give an idea of the basis of the research's purpose and discuss in-depth the findings in the field, and from there, researchers can give something new from this research. please add Conclusions must certainly be able to answer from the purpose of this study. *** I found the strengths of this article, but there are still weaknesses that need to be fixed. This article is Acceptable in Plos One with Major Revision Reviewer #3: Thank you for providing me the opportunity to review this manuscript. Overall I found this manuscript to be an interesting read, describing the disparity in knowledge of naloxone and opioid overdoses and be impacted by systemic issues related to race. It is a timely reminder that we all need to do more in our work to ensure the right messages are reaching the right people, regardless of race or other factors. I think there are two areas of improvement needed for this manuscript: 1) being concise, and 2) clearly describing all statistical analyses completed. I am a firm believer of using less words where possible, and I would suggest the authors look at areas where they could reduce the word count. At times, some sections felt overly described. Perhaps the section that stood out to me the most was when describing listwise deletion and why it was used. I would assume most people reading would understand listwise deletion, and that it's use when describing could be said it in fewer words. As another suggestion to shorten the methods, is provide the survey instrument as a supplementary to reduce the word count in the methods when describing the survey. I appreciate the authors have submitted to a non-addiction or drug and alcohol journal, and therefore at times need to describe certain concepts in greater details. I was confused as the methods made no mention of using chi-square or t-test analyses, and yet table 1 and table 2 have results from these tests. It was not until i noticed the footnotes of each table that i realized these tests were completed for each table. It would be important to ensure this is adequately described within the statistical analyses section. Did the authors utilize a Bonferroni correction for the chi-square test? We're there further analyses completed that as a reader I am not aware of? Otherwise, no major issues with the content of this manuscript. A few minor typos, but otherwise a sound paper that requires some finessing. Reviewer #4: For author and editor, Review of the submission #PONE-D-24-50788: Opioid Overdose and Naloxone Administration Knowledge and Perceived Competency in A Probability Sample of Indiana Urban Communities with Large Black Populations". This Original Research Report is in accordance with focus and scope of PLOS One. The manuscript is related to an original theme and relevant to the area. Considerations, corrections and suggestions are in the attached file. Considering the scientific merit and originality of the manuscript, the recommendation is: “MINOR REVISION”. Cordially. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Imaduddin Hamzah Reviewer #3: No Reviewer #4: Yes: Pablo Guilherme Caldarelli ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Seo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 03 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Junghwan Kim Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #1: 1- Section 2.2, paragraph 1.explain how these areas were chosen beyond demographic criteria 2- Section 2.3.3. ...defined by whether individual had personally experienced an opioid overdose or had a family member or close friend who died 3- Section 2.3.3, Table 1. confusing 4- Tables 3 and 4, Results narrative 5- Results sections rely only on tables 6- Discussion paragraphs 1 and 2 closely mirror Results 7- Abstract is dense and underrepresents key findings in plain language. 8- Citations 5, 7, 40 used heavily 9- No discussion of studies that show minimal or no racial difference in naloxone administration 10- No figures 11- Table captions could better explain 12- Reviewer #2: This article may be corrected as follows : Please look again at the author's guidelines on abstract, where abstract is mapped with background, objective, result and conclusion. A good abstract already looks what is novelty in this article. In the introduction, I have not found any Research Gap, so researchers need to improve; wherefrom the Research Gap, researchers can give something new from this research, and I have found what is offered by researchers as Novelty. In results and discussion should give an idea of the basis of the research's purpose and discuss in-depth the findings in the field, and from there, researchers can give something new from this research. *** I found the strengths of this article, but there are still weaknesses that need to be fixed. This article is Acceptable with Minor Revision in Plos Ones Journal Reviewer #3: The authors have addressed comments by reviewers sufficiently and I have no further suggestions for this manuscript. Reviewer #4: For authors and Editor, Review of the submission ID PONE-D-24-50788R1: “Opioid Overdose and Naloxone Administration Knowledge and Perceived Competency in A Probability Sample of Indiana Urban Communities with Large Black Populations” Thank you very much for submitting the manuscript to the PLOS One. The revisions that you made to the manuscript are very effective in addressing the remaining concerns. Following the review of the previous version, considering the scientific merit, the originality of the manuscript and the reading of the new version, the recommendation is: "ACCEPT". Congratulation one your fine research! Cordially, ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Yousra Nomeir Reviewer #2: Yes: ok Reviewer #3: No Reviewer #4: Yes: Pablo Guilherme Caldarelli ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 2 |
|
Opioid Overdose and Naloxone Administration Knowledge and Perceived Competency in A Probability Sample of Indiana Urban Communities with Large Black Populations PONE-D-24-50788R2 Dear Dr. Seo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Junghwan Kim Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-50788R2 PLOS ONE Dear Dr. Seo, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Junghwan Kim Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .